AG
YTEN

Aperio Group’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Aperio Group’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1
Closed -$76K – 1917
2014
Q3 		$76K Hold
1
– – ﹤0.01% 1699
2014
Q2 		$72K Hold
1
– – ﹤0.01% 1698
2014
Q1 		$108K Buy
+1
New +$79.2K ﹤0.01% 1954
2013
Q4 		– Sell
-1
Closed -$67K – 1902
2013
Q3 		$105K Hold
1
– – ﹤0.01% 1726
2013
Q2 		$118K Buy
+1
New +$96.7K ﹤0.01% 1567

Other funds holding YTEN

BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FA
FCG Advisors Chatham, New Jersey $425M AUM 12.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCM
McRae Capital Management Morristown, New Jersey $508M AUM 14.21% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Aperio Group's YTEN Position: Q4 2014 in Review

Aperio Group sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q4 2014, closing a stake of 1 share — an estimated $76K sold.

Aperio Group first reported a position in YTEN in Q2 2013 and held it in 5 quarters. The position peaked at $118K in Q2 2013. 15 funds tracked by Wall St. Rank hold YTEN as of Q4 2014.

  • Aperio Group reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
  • Aperio Group sold 1 Yield10 Bioscience, Inc. Common Stock share in Q4 2014, an estimated $76K.
  • Aperio Group first reported a position in Yield10 Bioscience, Inc. Common Stock in Q2 2013 and held it in 5 quarters.
  • Aperio Group's Yield10 Bioscience, Inc. Common Stock position peaked at $118K in Q2 2013.
  • 15 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q4 2014.

Based on Aperio Group's 13F filing for Q4 2014, filed 30 Jan 2015.